What 156 Derm Owners Just Told Us About 2026

For years, independent dermatology owners have described the same pressures without a number attached to any of them. We surveyed 156 practice owners about running a derm practice in 2026, and the answers put hard figures on what used to live only in hallway conversations.

Most surveys of dermatology ask the wrong people. The AMA, Medscape, and the AAD survey dermatologists about burnout, clinical trends, and compensation, not the people who own the practice about the work of running it. Every respondent here holds an ownership or equity stake, so every answer comes from someone who signs the checks and carries the risk.

One pattern shows up before any single statistic does. Dermatology doesn't have one dominant problem right now. It has several, arriving at once: AI is changing the exam room, private equity is knocking, reimbursement keeps tightening, and staffing stays hard. The distribution is the story.

Start with the finding the press ran with. 93% of the owners we surveyed say patients now arrive with AI-generated diagnoses at least a few times a week, and 58% see it daily. They walk in holding a printout from ChatGPT or a Google AI Overview that already names a condition.

That number has no precedent. Deloitte found that 37% of US consumers used generative AI for a health question in 2024, and the AMA's 2026 survey reports that 81% of physicians now use AI professionally, up from 38% in 2023. But those surveys measured whether patients use AI and whether physicians assume they do. Nobody had counted how often a dermatologist actually faces a patient holding one. Ours is the first to put a frequency on it.

The clinical version is messier. One dermatologist, Dr. Bronfenbrenner, told Dermatology Times about a patient who arrived with a Gemini printout suggesting eczema and topical steroids. The actual diagnosis was shingles, and the patient left with Valtrex. As the doctor put it, "at the end of the day he got the correct diagnosis, which is important."

The resilient read sits in the same data: across the full survey, 88% of practices already use AI themselves, for scheduling, billing, documentation, and diagnostic support.

The finding that deserves more attention: revenue that leaks out before anyone notices. 46% of owners told us they don't regularly review their own financials, which splits two ways: 22% review the numbers only occasionally, and 24% hand the job entirely to an administrator or billing team.

Then the survey does something unusual. We cross-tabbed how closely owners watch their financials against how much they believe they lose to coding errors and denials. The owners who review their numbers regularly reported higher losses, not lower. Among those watchers, 33% put their leakage at 6 to 10% and 16% put it between 11 and 15%. Among the owners who don't watch closely, 35% estimated their losses at under 3%.

The direction is counterintuitive, but it does not mean attention causes losses. It means the owners looking closely can see leakage that the owners not looking can't. The gap is one of visibility, not performance. No credible third-party benchmark for practice-level leakage exists, which is why owners are guessing. We made a version of this case in Collections Look Fine. These 4 Metrics Say Otherwise; the survey turns it into a number.

PE is the pressure owners hear about most. 86% of the independent owners in our sample have been approached by a PE firm or consolidator. On selling within five years, 46% said somewhat or very likely, 45% landed in neutral or unsure, and only 9% ruled it out.

The reason is the part worth sitting with. 34% named operational support as their leading reason to consider PE, ahead of financial security or an exit at 30% and admin burden at 24%. Owners aren't lining up to cash out; they're weighing whether they want to keep carrying the operational load alone. PE isn't only buying practices; it's absorbing the back office that owners are tired of running.

Dermatology is not shrinking. Across the full survey, 73% of owners report demand rising over the past three years, 30% of them significantly. The strain is on the supply side. 67% feel pressure to see more patients than they consider clinically ideal, 62% called hiring qualified staff difficult over the last two years, and 23% are currently understaffed.

One thread runs through every one of these pressures: visibility. The AI patient, the invisible leakage, the PE offer, and the staffing crunch are all harder to manage when an owner runs the practice on feel instead of numbers. It is the frame Clarity CEO Ashwin Krishnan returns to. "Having the visibility into what is actually driving your practice, rather than managing the practice based on feel, is really what separates the practices that thrive from the ones that don't," he told Dermatology Times. His read on PE follows from it: PE wins because it brings operational discipline, and independents with the same discipline don't have to sell. It is also the argument behind why your most valuable hour isn't in the exam room.

The overall picture points toward adaptation. Adoption is high, demand is healthy, and owners are adjusting to a business that got more complicated on its own. As Krishnan puts it, the job now is "building the operational rigor to meet that demand."

1. Put your financials on a fixed schedule. If you're one of the 46% reviewing occasionally or delegating entirely, start with a monthly look at three numbers: net collection rate, denial rate, and days in AR. Delegate the work if you must, but keep the visibility.

2. Give your staff a script for the AI patient. 58% of owners see AI-generated diagnoses daily. A short protocol for acknowledging the printout and steering back to the exam keeps the visit on track.

3. Treat a PE approach as an operations question first. Before the meeting, name the specific operational burden you want to hand off. Among independent owners, 34% cite operational support as their top reason to consider PE, so fixing the operations you can fix yourself changes what you're negotiating for.

_{Survey of 156 US dermatologists with an ownership or equity stake, fielded by PureSpectrum in March 2026. 80% independent, 20% PE-backed, ranging from solo to multiprovider groups across urban, suburban, and rural markets.}

Clarity RCM manages revenue cycle for 200+ dermatology practices across 42 states. It's all we do. See how we work.